HomeANIP • NASDAQ
add
ANI Pharmaceuticals Inc Common Stock
Previous close
$98.73
Day range
$97.18 - $99.10
Year range
$52.50 - $99.50
Market cap
2.12B USD
Avg Volume
634.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 211.37M | 53.12% |
Operating expense | 121.59M | 70.50% |
Net income | 8.55M | 473.81% |
Net profit margin | 4.04 | 343.37% |
Earnings per share | 1.80 | 76.47% |
EBITDA | 38.45M | 62.07% |
Effective tax rate | 18.77% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 223.52M | -9.53% |
Total assets | 1.34B | 45.86% |
Total liabilities | 881.39M | 100.25% |
Total equity | 461.61M | — |
Shares outstanding | 20.09M | — |
Price to book | 4.55 | — |
Return on assets | 2.88% | — |
Return on capital | 3.51% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 8.55M | 473.81% |
Cash from operations | 75.81M | 335.35% |
Cash from investing | -6.91M | -55.29% |
Cash from financing | -1.75M | -20.32% |
Net change in cash | 68.00M | 490.61% |
Free cash flow | 65.36M | 330.91% |
About
Founded
2001
Headquarters
Website
Employees
897
